you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

BSE Live

Apr 13, 16:00
2154.05 0.30 (0.01%)
Volume
AVERAGE VOLUME
5-Day
44,439
10-Day
26,965
30-Day
15,127
29,974
  • Prev. Close

    2153.75

  • Open Price

    2177.50

  • Bid Price (Qty.)

    2130.00 (3)

  • Offer Price (Qty.)

    2154.05 (6)

NSE Live

Apr 13, 15:57
2159.05 6.10 (0.28%)
Volume
AVERAGE VOLUME
5-Day
516,936
10-Day
358,347
30-Day
280,979
413,974
  • Prev. Close

    2152.95

  • Open Price

    2184.85

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2159.05 (3018)

Financials

2020 2019 2018 2017 2016
Nine Months Results of Ipca Laboratories (in Rs. Cr.) Dec '20 Dec '19 Dec '18 Dec '17 Dec '16  
Net Sales/Income from operations 4,098.24 3,362.64 2,799.34 2,436.46 2,405.27  
Other Operating Income -- -- -- -- 48.68  
Total Income From Operations 4,098.24 3,362.64 2,799.34 2,436.46 2,453.95  
EXPENDITURE  
Consumption of Raw Materials 1,146.23 1,060.04 831.88 699.66 715.64  
Purchase of Traded Goods 127.75 153.80 123.83 125.22 120.86  
Increase/Decrease in Stocks 7.42 -60.08 -64.93 31.61 39.05  
Power & Fuel -- -- -- -- --  
Employees Cost 711.04 642.91 575.42 544.22 516.19  
Depreciation 139.15 133.31 130.27 131.21 128.22  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 808.86 843.93 814.64 704.00 695.28  
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,157.79 588.73 388.23 200.54 238.71  
Other Income 42.33 51.39 40.01 28.15 16.99  
P/L Before Int., Excpt. Items & Tax 1,200.12 640.12 428.24 228.69 255.70  
Interest 5.83 12.32 12.24 17.57 23.20  
P/L Before Exceptional Items & Tax 1,194.29 627.80 416.00 211.12 232.50  
Exceptional Items -- -- -- -- --  
P/L Before Tax 1,194.29 627.80 416.00 211.12 232.50  
Tax 205.00 103.10 70.56 29.32 88.60  
P/L After Tax from Ordinary Activities 989.29 524.70 345.44 181.80 143.90  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 989.29 524.70 345.44 181.80 143.90  
Equity Share Capital 25.37 25.27 25.27 25.24 25.24  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 78.16 41.53 27.34 14.41 11.40  
Diluted EPS 78.16 41.51 27.34 14.41 11.40  
EPS After Extra Ordinary  
Basic EPS. 78.16 41.53 27.34 14.41 11.40  
Diluted EPS. 78.16 41.51 27.34 14.41 11.40  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited